Request Demo
Last update 23 Jan 2025
Adenocarcinoma of pancreas with NRG1 fusion
Last update 23 Jan 2025
Basic Info
Synonyms Adenocarcinoma of pancreas with NRG1 (neuregulin 1) fusion, Adenocarcinoma of pancreas with NRG1 fusion, Adenocarcinoma of pancreas with neuregulin 1 gene fusion + [3] |
Introduction- |
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
NCT02912949
A Phase I/II Study of MCLA-128, a Full Length IgG1 Bispecific Antibody Targeting HER2 and HER3, in Patients With Solid Tumors (eNRGy)
100 Clinical Results associated with Adenocarcinoma of pancreas with NRG1 fusion
Login to view more data
100 Translational Medicine associated with Adenocarcinoma of pancreas with NRG1 fusion
Login to view more data
Login to view more data
Analysis
Perform a panoramic analysis of this field.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free